BMP Debate: evidence in the name of science?

[摘要] Spine surgery and spine surgeons have become attractive magnets for media attention…unfortunately, often the wrong kind of media attention.1,2 The recently unfolding debate among some of the biggest academic names in North American spine surgery touches on the subjects of recombinant human bone morphogenic protein-2 (Infuse™, Medtronic, Memphis, TN), off-label use of implants, conflict of interest, and expectations regarding financial disclosure and has expanded into a public mudslinging using the North American Spine Society's journal The Spine Journal (E Carragee, editor-in-chief) as its primary vehicle with many news outlets having jumped onboard.3,4,5 Let's take a brief look at the two primary issues at stake here: (1) the actual science in dispute; (2) the issue of academic and research integrity.

[学科分类] 外科医学